Found 89 matching trials
MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV PHASE4 MAIN STUDY: The purpose of this study is to determine if teriflunomide will...
Show More Location
Phoenix Neurological Associates, Ltd
Learn More & Join Trial
Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis PHASE2 International multicenter, randomized, double-blind, double-masked, placebo...
Show More Location
State Budgetary Healthcare Institution of Nizhny Novgorod region "Regional Clinical Hospital N.A. Semashko, Nizhny Novgorod"
Learn More & Join Trial
Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome PHASE3 Multiple sclerosis (MS) is a common cause of severe neurological disability...
Show More Learn More & Join Trial
Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study N/A The goal of this retrospective observational study is to investigate the lo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS PHASE2 The investigators propose to design and conduct a phase II clinical trial t...
Show More Location
Antwerp University Hospital
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) PHASE3 A study to evaluate the efficacy and safety of fenebrutinib on disability p...
Show More Status
Active Not Recruiting
Location
University of Alabama Birmingham
Learn More & Join Trial
A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period PHASE3 National, multicenter study:
The study consists of 3 periods:
1. A baseli...
Show More Learn More & Join Trial
Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis PHASE3 Primary Objective:
To measure the effect of Teriflunomide on lymphocytes s...
Show More Location
Investigational Site Number 056001
Learn More & Join Trial
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients PHASE4 Primary Objective:
To describe efficacy, tolerability and convenience of t...
Show More Location
Investigational Site Number 840077
Learn More & Join Trial
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) PHASE3 To compare the efficacy and safety of remibrutinib versus teriflunomide in ...
Show More Status
Active Not Recruiting
Location
AZ Integrated Neuro and Spine
Learn More & Join Trial